deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test Full post here: https://www.globenewswire.com/news-release/2024/12/02/2989457/0/en/deepull-receives-FDA-Breakthrough-Device-Designation-for-its-UllCORE-Bloodstream-Infection-Test.html
Author: Laia Romero
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology
VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath Bioventures. Funding will be used to advance clinical trials for BCI therapeutics and support the team expansion to accelerate development and commercialization. More information here: https://www.businesswire.com/news/home/20241029660063/en/INBRAIN-Neuroelectronics-Raises-50M-Series-B-to-Advance-Graphene-Based-Brain-Computer-Interface-Technology
INBRAIN Neuroelectronics Announces World’s First Human Graphene-Based Brain Computer Interface Procedure
You can read full information here:https://www.manchester.ac.uk/about/news/inbrain-neuroelectronics-announces-worlds-first-human-graphene-based-brain-computer-interface-procedure/
Peptomyc S.L. Expands its Patent Portfolio with a Patent Grant in Hong Kong for its Methods and Composition for the Treatment of Cancer
Barcelona, 19th of August 2024 Peptomyc S.L., a company developing foundational mini-protein therapeutics for the treatment of cancer, announces today that the Company has been issued a patent by the Hong Kong Patent Office protecting its Methods and Composition of Matter. “We are delighted to announce further protection of our mini-protein therapeutics in Hong Kong. This patent grant strengthens our patent portfolio that protects our unique mini-protein therapeutics, which are able…
Todosalud Incorporates Mediktor’s AI into Its Services as Part of Its Commitment to Innovation
MEDELLÍN, Colombia. June 29, 2024 – Synergia Inversiones and Negocios S.A.S. are adding Mediktor’s advanced AI virtual assistant, called Frank, to its todosalud digital health platform. Users will have access to a 24/7 solution to assess their symptoms and be directed to the appropriate level of care. You can read the full post here: https://www.mediktor.com/es/news/press/todosalud-incorporates-mediktors-ai-into-its-services-as-part-of-its-commitment-to-innovation
Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions
BARCELONA, ESP. and SAN FRANCISCO, CA. June 4th 2024 — Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San Francisco-based, digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. This consolidation of two world-leading artificial intelligence-driven solutions providers marks a major medical technology milestone, extending Mediktor’s global presence to more than 35 countries and expanding its…
HUAV Partners with Mediktor for Improved Urgent Care Management
Hospital Universitario Arnau de Vilanova (HUAV) is a healthcare provider in Lleida, Alto Pirineo y Arán, and parts of La Franja in Aragón, Spain. Healthcare professionals were struggling with overcrowded waiting rooms, and the HUAV was looking for a digital solution to help manage urgent care effectively. Full article: https://www.mediktor.com/es/news/news/huav-partners-with-mediktor-for-improved-urgent-care-management
deepull appoints Didier Deltort to its Board of Directors
You can read here the whole post https://www.globenewswire.com/news-release/2024/05/22/2886202/0/en/deepull-appoints-Didier-Deltort-to-its-Board-of-Directors.html
Hospital Clínic Barcelona Collaborates with Mediktor for Improved Patient Assistance in Tropical Diseases
Read the full press release here: https://www.mediktor.com/es/news/news/hospital-clinic-barcelona-collaborates-with-mediktor-for-improved-patient-assistance-in-tropical-diseases
Accure Therapeutics awarded €1 million from Spanish government to evaluate ACT-03 for post-traumatic epilepsy
Read the full press release here: https://accure.health/accure-therapeutics-awarded-e1-million-from-spanish-government-to-evaluate-act-03-for-post-traumatic-epilepsy/